Ralph S. Baric

Infectious Diseases · 2003–2020

A researcher in the Science corpus: 39 papers; trusts 10 researchers and is trusted by 11 researchers here, as inferred from the citation graph.

Subfields

• Infectious Diseases — 533 citations into it; #72 of 589 by trust here, #5 by citations
• Animal Science and Zoology — 210 citations into it; #101 of 476 by trust here, #2 by citations
• Molecular Biology — 122 citations into it
• Epidemiology — 93 citations into it
• Neurology — 52 citations into it

Whom Ralph S. Baric trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. P. Masters
2. S. Perlman
3. Fang Li
4. Patrick C. Y. Woo
5. Susanna K. P. Lau

Who trusts Ralph S. Baric overall

1. Fang Li
2. S. Weiss

Papers from Ralph S. Baric's perspective

Ordered by how strongly the researchers Ralph S. Baric trusts endorse each paper. Same corpus, a different order for every researcher.

1. Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China (Science)
2. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia (Journal of Virology)
3. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. (Proceedings of the National Academy of Sciences of the United States of America)
4. A previously undescribed coronavirus associated with respiratory disease in humans. (Proceedings of the National Academy of Sciences of the United States of America)
5. Identification of a new human coronavirus (Nature Medicine)
6. Virus-encoded proteinases and proteolytic processing in the Nidovirales. (Journal of General Virology)
7. What’s new in the renin-angiotensin system?
8. Coronavirus Diversity, Phylogeny and Interspecies Jumping (Experimental biology and medicine)
9. Bats Are Natural Reservoirs of SARS-Like Coronaviruses (Science)
10. Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans (mBio)

Their papers

• Sharing and community curation of mass spectrometry data with GNPS (2016) — 3,861 citations
• Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (2020) — 974 citations
• Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme (2015) — 236 citations
• The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients (2020) — 843 citations
• SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract (2020) — 1,406 citations
• Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity (2020) — 1,662 citations
• Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2 (2020) — 428 citations
• An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice (2020) — 993 citations
• Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group (2020) — 1,586 citations
• Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV (2020) — 1,642 citations
• SARS-CoV-2 infection protects against rechallenge in rhesus macaques (2020) — 813 citations
• The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (2020) — 6,134 citations
• SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness (2020) — 1,369 citations
• Animal models for COVID-19 (2020) — 803 citations
• Single-Shot Ad26 Vaccine Protects Against SARS-CoV-2 in Rhesus Macaques (2020) — 806 citations
• DNA vaccine protection against SARS-CoV-2 in rhesus macaques (2020) — 1,010 citations
• Potently neutralizing and protective human antibodies against SARS-CoV-2 (2020) — 1,004 citations
• Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (2020) — 1,289 citations
• A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (2020) — 586 citations
• SARS-CoV-2 D614G Variant Exhibits Efficient Replication ex vivo and Transmission in vivo (2020) — 837 citations